Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Digital Rehabilitation With Wearable Monitors for Sequential Lung Cancer Resection

NCT: NCT07797075 · NOT_YET_RECRUITING

NCT IDNCT07797075
StatusNOT_YET_RECRUITING
Start Date2026-08-31
Completion2028-08-31
SponsorWest China Hospital (OTHER)
First posted
Last updated

Brief Summary

This is a prospective, open-label, parallel-group, 1:1 randomized controlled trial designed to evaluate whether a digital rehabilitation program integrated with wireless wearable continuous monitoring devices can shorten the time to functional recovery in patients with multiple primary non-small cell lung cancer (MPLC) who undergo sequential (two-stage) curative-intent resection. Eligible participants will be randomly assigned to either the intervention group or the control group. Both groups will receive standard enhanced recovery after surgery (ERAS) care. In addition, the intervention group will receive continuous vital sign monitoring (using a wearable patch during hospitalization and a wrist-worn device after discharge), personalized exercise prescriptions with daily step targets, and high-frequency electronic patient-reported outcome (ePRO) follow-up with threshold-triggered response. The control group will receive standard intermittent vital sign monitoring and conventional rehabilitation education. The primary endpoint is the time from the first surgery to attainment of functional recovery criteria sufficient for second-stage surgery readiness (assessed by a composite of step count recovery, functional interference score combined with 6-minute walk distance, or multidisciplinary team determination). Secondary endpoints include pulmonary function recovery (FEV1%, FVC%, DLCO% at 3 months), physical activity (daily steps, moderate-to-vigorous physical activity, 6-minute walk distance), symptom burden and quality of life (EORTC QLQ-C30/LC13, PROMIS), 30- and 90-day complication and readmission rates, second-surgery-related outcomes, adherence, safety, and healthcare resource utilization. A total of 222 participants (111 per group) will be enrolled. The study will be conducted at West China Hospital of Sichuan University from June 2026 to October 2027. The findings are expected to provide high-quality evidence on the clinical utility of wearable-integrated digital rehabilitation in the perioperative management of MPLC patients undergoing sequential resection.

Frequently Asked Questions

What is Digital Rehabilitation With Wearable Monitors for Sequential Lung Cancer Resection?

Digital Rehabilitation With Wearable Monitors for Sequential Lung Cancer Resection is a clinical trial registered under NCT07797075. Current status: NOT_YET_RECRUITING.

What is the status of NCT07797075?

The current status of NCT07797075 (Digital Rehabilitation With Wearable Monitors for Sequential Lung Cancer Resection) is: NOT_YET_RECRUITING.

When did Digital Rehabilitation With Wearable Monitors for Sequential Lung Cancer Resection start?

Digital Rehabilitation With Wearable Monitors for Sequential Lung Cancer Resection started on 2026-08-31.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.